Laurion Capital Management LP - CRINETICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$10,308,984
+487.4%
346,637
+333.6%
0.06%
+200.0%
Q1 2022$1,755,000
-48.0%
79,952
-32.1%
0.02%
-36.4%
Q3 2018$3,372,000117,7000.03%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$76,819,0007.66%
RA Capital Management 1,875,209$42,680,0001.84%
Perceptive Advisors 2,587,953$58,901,0001.66%
EMORY UNIVERSITY 97,035$2,209,0001.55%
New Leaf Venture Partners, L.L.C. 167,700$3,817,0001.05%
Orbimed Advisors 1,914,282$43,569,0000.67%
Opaleye Management Inc. 73,000$1,661,0000.46%
Novo Holdings A/S 135,009$3,073,0000.46%
Virtus ETF Advisers LLC 7,934$181,0000.38%
Eventide Asset Management 384,000$8,740,0000.30%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders